Parallel Advisors, LLC Sangamo Therapeutics, Inc Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 20, 2024	BUY	$1.66 - $3.67 $2,705 - $5,982	1,630 New	1,630 $2,000
Q1 2023 Apr 25, 2023	BUY	$1.66 - $3.67 $1,948 - $4,308	1,174 Added 257.46%	1,630 $2,000
Q4 2022 Feb 03, 2023	BUY	$2.77 - $5.07 $1,263 - $2,311	456 New	456 $1,000
Q1 2022 Apr 28, 2022	SELL	$5.23 - $7.82 $617 - $922	-118 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$7.29 - $10.97 $1,939 - $2,918	-266 Reduced 69.27%	118 $1,000
Q3 2021 Nov 02, 2021	BUY	$9.01 - $12.01 $2,396 - $3,194	266 Added 225.42%	384 $3,000
Q1 2020 Apr 27, 2020	BUY	$5.05 - $8.85 $595 - $1,044	118 New	118 $0

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.